Shares of Addus Homecare Co. (NASDAQ:ADUS) have earned an average recommendation of “Buy” from the six analysts that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $70.67.
ADUS has been the subject of several research analyst reports. BidaskClub cut Addus Homecare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 12th. ValuEngine upgraded Addus Homecare from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Stephens raised their price objective on Addus Homecare from $67.00 to $75.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 7th. Zacks Investment Research cut Addus Homecare from a “buy” rating to a “strong sell” rating in a research note on Monday, June 11th. Finally, Oppenheimer raised their price objective on Addus Homecare from $50.00 to $72.00 and gave the stock an “outperform” rating in a research note on Wednesday.
Shares of Addus Homecare traded down $0.50, hitting $64.15, during trading on Friday, Marketbeat.com reports. The stock had a trading volume of 52,633 shares, compared to its average volume of 96,498. Addus Homecare has a 12-month low of $30.95 and a 12-month high of $71.78. The stock has a market cap of $756.23 million, a price-to-earnings ratio of 40.66, a PEG ratio of 2.17 and a beta of -0.39. The company has a quick ratio of 3.01, a current ratio of 3.09 and a debt-to-equity ratio of 0.53.
Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings data on Tuesday, August 7th. The company reported $0.50 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.51 by ($0.01). Addus Homecare had a return on equity of 10.45% and a net margin of 3.43%. The firm had revenue of $131.24 million during the quarter, compared to analysts’ expectations of $127.81 million. equities analysts anticipate that Addus Homecare will post 1.63 EPS for the current fiscal year.
A number of hedge funds have recently made changes to their positions in ADUS. Bank of New York Mellon Corp raised its position in Addus Homecare by 6.2% during the fourth quarter. Bank of New York Mellon Corp now owns 89,846 shares of the company’s stock valued at $3,127,000 after acquiring an additional 5,265 shares in the last quarter. BlackRock Inc. raised its position in Addus Homecare by 1.1% during the fourth quarter. BlackRock Inc. now owns 437,855 shares of the company’s stock valued at $15,238,000 after acquiring an additional 4,670 shares in the last quarter. Renaissance Technologies LLC raised its position in Addus Homecare by 2.4% during the fourth quarter. Renaissance Technologies LLC now owns 72,800 shares of the company’s stock valued at $2,533,000 after acquiring an additional 1,700 shares in the last quarter. Deutsche Bank AG raised its position in Addus Homecare by 51.6% during the fourth quarter. Deutsche Bank AG now owns 40,114 shares of the company’s stock valued at $1,393,000 after acquiring an additional 13,655 shares in the last quarter. Finally, Goldman Sachs Group Inc. purchased a new position in Addus Homecare during the fourth quarter valued at approximately $258,000. Institutional investors own 90.89% of the company’s stock.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Recommended Story: How to Use the New Google Finance Tool
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.